(Q38141793)

29 August 2017

title

MRI-targeted prostate biopsy: a review of technique and results (English)

1 reference

29 August 2017

0 references

3

Caroline M Moore

1 reference

29 August 2017

2

Mark Emberton

1 reference

29 August 2017

Nicola L Robertson

1

1 reference

29 August 2017

language of work or name

English

0 references

publication date

24 September 2013

1 reference

29 August 2017

published in

Nature Reviews Urology

1 reference

29 August 2017

volume

10

1 reference

29 August 2017

issue

10

1 reference

29 August 2017

page(s)

589-597

1 reference

Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Ultrasound for prostate imaging and biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Active surveillance for low-risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Prospective Assessment of Prostate Cancer Aggressiveness Using 3-T Diffusion-Weighted Magnetic Resonance Imaging–Guided Biopsies Versus a Systematic 10-Core Transrectal Ultrasound Prostate Biopsy Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Guided e-MRI prostate biopsy can solve the discordance between Gleason score biopsy and radical prostatectomy pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Real-time Virtual Sonography for navigation during targeted prostate biopsy using magnetic resonance imaging data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Accuracy of MRI/MRSI-based transrectal ultrasound biopsy in peripheral and transition zones of the prostate gland in patients with prior negative biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

The Clinical Value of Performing an MRI before Prostate Biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Potential of (1)H MR spectroscopic imaging to segregate patients who are likely to show malignancy of the peripheral zone of the prostate on biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Prospective comparison of T2w-MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

The value of endorectal MR imaging to predict positive biopsies in clinically intermediate-risk prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Areas Suspicious for Prostate Cancer: MR–guided Biopsy in Patients with at Least One Transrectal US-guided Biopsy with a Negative Finding—Multiparametric MR Imaging for Detection and Biopsy Planning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

MR-compatible assistance system for biopsy in a high-field-strength system: initial results in patients with suspicious prostate lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Prostate biopsy in the supine position in a standard 1.5-T scanner under real time MR-imaging control using a MR-compatible endorectal biopsy device

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

How good is MRI at detecting and characterising cancer within the prostate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Comparison of pelvic phased-array versus endorectal coil magnetic resonance imaging at 3 Tesla for local staging of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

ESUR prostate MR guidelines 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Correlation of Gleason scores with diffusion-weighted imaging findings of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Magnetic resonance imaging targeted biopsy in men with previously negative prostate biopsy results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Detection and localization of prostate cancer with the targeted biopsy strategy based on ADC map: a prospective large-scale cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

T2-weighted MR imaging of prostate cancer: multishot echo-planar imaging vs fast spin-echo imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Do additional cores from MRI cancer-suspicious lesions to systematic 12-core transrectal prostate biopsy give better cancer detection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Clinical application of a 3D ultrasound-guided prostate biopsy system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Magnetic resonance image-guided biopsies with a high detection rate of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Dynamic Contrast-enhanced–magnetic Resonance Imaging Evaluation of Intraprostatic Prostate Cancer: Correlation with Radical Prostatectomy Specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Prostate cancer risk inflation as a consequence of image-targeted biopsy of the prostate: a computer simulation study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Incidental prostatic carcinoma detected by MRI and diagnosed by MRI/CT-guided biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Morphologic, functional, and metabolic magnetic resonance imaging-guided prostate biopsy in a patient with prior negative transrectal ultrasound-guided biopsies and persistently elevated prostate-specific antigen levels.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Detection of prostate cancer by magnetic resonance imaging and spectroscopy in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Combination of signal intensity measurements of lesions in the peripheral zone of prostate with MRI and serum PSA level for differentiating benign disease from prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Prostate cancer detection using an extended prostate biopsy schema in combination with additional targeted cores from suspicious images in conventional and functional endorectal magnetic resonance imaging of the prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

MR-guided transgluteal biopsies with an open low-field system in patients with clinically suspected prostate cancer: technique and preliminary results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils. Local staging accuracy of prostate cancer using endorectal coil MR imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Prostate MRI: who, when, and how? Report from a UK consensus meeting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Is it possible to model the risk of malignancy of focal abnormalities found at prostate multiparametric MRI?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Multi-parametric magnetic resonance imaging to rule-in and rule-out clinically important prostate cancer in men at risk: a cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Evaluation of a structured report of functional prostate magnetic resonance imaging in patients with suspicion for prostate cancer or under active surveillance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.196

Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner

31 March 2020

1 reference

12 December 2020

Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system

1 reference

12 December 2020

3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils; Initial experience(1)

1 reference

12 December 2020

Diagnostic accuracy of MRI/MRSI for patients with persistently high PSA levels and negative TRUS-guided biopsy results

1 reference

12 December 2020

Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study

1 reference

12 December 2020

Using biopsy to detect prostate cancer.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2013.196

1 reference

Dimensions Publication ID

29 August 2017

1006869926

0 references

1 reference